CESTAT Chennai Settles Classification of Imported Dialysis Solutions

Aadrikaa Legal Services (ALS) – IDT Tax I Arbitration I Litigation

Date: 25.04.2026

CESTAT Chennai Settles Classification of Imported Dialysis Solutions

​​ ​​   ​​ ​ ​​​  ​ ​

This article provides a detailed overview of a significant legal order issued by the Customs, Excise & Service Tax Appellate Tribunal (CESTAT), Chennai, regarding the classification of imported medical dialysis solutions. The case involves M/s. Baxter (India) Pvt. Ltd. and addresses the correct customs tariff heading for “Extraneal Peritoneal Dialysis Solution with 7.5% Icodestrin, Fnb4984t Dialysis Fluids C.A.P.D.” The outcome has important implications for importers, customs authorities, and the broader medical industry.

Background of the Case

M/s. Baxter (India) Pvt. Ltd. imported dialysis solutions and filed Home Consumption Bills of Entry, seeking classification under Customs Tariff Heading (CTH) 9018. This heading pertains to instruments and appliances used in medical, surgical, dental, or veterinary sciences. However, customs authorities reclassified the goods under CTH 3004, which covers medicaments for therapeutic or prophylactic uses. This reclassification denied Baxter the benefit of certain exemption notifications, resulting in a demand notice and subsequent legal proceedings.

Key Events:

• Bills of Entry Filed: May and June 2010 for dialysis solutions.
• Initial Classification Sought: CTH 9018 (medical instruments/appliances).
• Reclassification by Authorities: CTH 3004 (medicaments).
• Exemption Denied: Under Notification No.21/2002, Sl.No.357A, and Notification No.06/2006-Central Excise, Sl. No.59.
• Demand Notice Issued: October 2010 under Section 28(1) of Customs Act, 1962.
• Order-in-Original Issued: August 2013, confirming the demand.
• Appeal Dismissed by Commissioner (Appeals): June 2025.
• Appeal to CESTAT Chennai: Resulted in the present order.

Legal Arguments and Tribunal’s Reasoning

The central issue was whether the imported dialysis solution should be classified under CTH 9018 or CTH 3004. Baxter argued that previous decisions, including those by the Chennai Bench and the Hon’ble Apex Court, had already settled the classification in their favor under CTH 9018.

The Tribunal reviewed:

• The impugned order and prior decisions.
• The Final Order No.40615/2015 (June 2015), which had considered identical goods and issues.
• The Apex Court’s decision in Baxter’s own case.
• Orders from Delhi and Kolkata Benches supporting Baxter’s position.

The Tribunal found that the Commissioner (Appeals) had already considered the relevant facts and justified classification under CTH 9018. Attempts to differentiate the facts in the impugned order were not persuasive.

Final Decision and Implications

The CESTAT Chennai concluded that the issue of classification for the dialysis solution was no longer open to debate (no more res integra). The Tribunal set aside the impugned order, allowed Baxter’s appeal, and granted consequential benefits as per law.

Key Takeaways:

• Classification Settled: Dialysis solutions like “Extraneal Peritoneal Dialysis Solution with 7.5% Icodestrin” are to be classified under CTH 9018.
• Exemption Benefits Restored: Importers are eligible for exemption notifications previously denied.
• Legal Precedent: The decision reinforces consistency across regional benches and aligns with the Apex Court’s ruling.

Conclusion

This CESTAT Chennai order is a landmark for importers of medical solutions, clarifying tariff classification and ensuring access to exemption benefits. It underscores the importance of judicial consistency and the role of appellate tribunals in resolving classification disputes. Importers should review their customs filings in light of this decision to ensure compliance and maximize benefits.

Source: CESTAT Chennai

Disclaimer

Handy Download:

Write to us at office@aadrikaalaw.com

Tel: +91-11-4999 2707 I +91-9999005379

www.aadrikaalaw.com